Trading Signals: CAPR Stock Price Prediction and Forecast (Tue. Apr. 1, 2003 - Fri. Jul. 2, 2021)(Capricor Therapeutics Inc)
| CAPR latest price $24.8000 (3.33%) ($23.1000 - $24.8000) on Tue. Feb. 7, 2017. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 4.58% (three month average) | RSI | 57 | Latest Price | $24.8000(3.33%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | CAPR advances 0.3% a day on average for past five trading days. | Weekly Trend | CAPR advances 2.4% a week on average for past two weeks. | Market Behavior | Value stocks sell-off for large cap. Value stock sell-off for small cap. | Correlated ETFs | Broad market will support CAPR advance at 0% a week (0% probability) EWI(7%) PEJ(7%) SKYY(7%) XLF(7%) ARKK(6%) | Factors Impacting CAPR price | CAPR will decline at least -2.29% in a week (0% probabilities). GDX(-7%) TLT(-6%) SIL(-6%) GLD(-6%) VIXM(-5%) | Explanation | The rally is not sustainable and not supported by the broad market. | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -2.29% (StdDev 4.58%) | Hourly BBV | 0 () | Intraday Trend | 2.9% | | | |
|
5 Day Moving Average | $24.46(1.39%) | 10 Day Moving Average | $23.69(4.69%) | 20 Day Moving Average | $23.97(3.46%) | To recent high | -22.5% | To recent low | 13.8% | Market Cap | $488m | | | | Capricor Therapeutics, Inc. engages in the discovery, development and commercialization of first-in-class biological therapies for the treatment of cardiac and other serious medical conditions. Its product candidate consists of CAP-1002, Cenderitide, Exosomes, CAP-1001, CU-NP and CSps. The company was founded in August 2005 and is headquartered in Beverly Hills, CA. |